Naproxen and esomeprazole magnesium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68788-4166
  • Package NDC 68788-4166-3
  • Package NDC 68788-4166-6
  • Application number ANDA213699
  • SPL ID 65b892f2-8385-4bb0-8121-a58b01e8d13d
  • SPL set ID 65b892f2-8385-4bb0-8121-a58b01e8d13d
  • UNII 57Y76R9ATQ
  • UNII R6DXU4WAY9
  • RxCUI 994005

What the source publishes

Labeler
Preferred Pharmaceuticals Inc.
Active ingredients
Naproxen and esomeprazole magnesium
Form
TABLET, DELAYED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68788-4166_65b892f2-8385-4bb0-8121-a58b01e8d13d
{
  "name": "Naproxen and esomeprazole magnesium",
  "splId": "65b892f2-8385-4bb0-8121-a58b01e8d13d",
  "labels": [
    {
      "setId": "65b892f2-8385-4bb0-8121-a58b01e8d13d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65b892f2-8385-4bb0-8121-a58b01e8d13d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65b892f2-8385-4bb0-8121-a58b01e8d13d"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Preferred Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4166-3)",
      "package_ndc": "68788-4166-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260723"
    },
    {
      "sample": false,
      "description": "60 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4166-6)",
      "package_ndc": "68788-4166-6",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260723"
    }
  ],
  "productId": "68788-4166_65b892f2-8385-4bb0-8121-a58b01e8d13d",
  "useDomain": "unknown",
  "dosageForm": "TABLET, DELAYED RELEASE",
  "productNdc": "68788-4166",
  "deaSchedule": null,
  "genericName": "Naproxen and esomeprazole magnesium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NAPROXEN",
      "strength": "375 mg/1"
    },
    {
      "name": "ESOMEPRAZOLE MAGNESIUM TRIHYDRATE",
      "strength": "20 mg/1"
    }
  ],
  "applicationNumber": "ANDA213699",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260723",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000000160",
      "M0001335",
      "N0000175722"
    ],
    "unii": [
      "57Y76R9ATQ",
      "R6DXU4WAY9"
    ],
    "rxcui": [
      "994005"
    ],
    "spl_set_id": [
      "65b892f2-8385-4bb0-8121-a58b01e8d13d"
    ],
    "pharm_class_cs": [
      "Anti-Inflammatory Agents, Non-Steroidal [CS]"
    ],
    "pharm_class_epc": [
      "Nonsteroidal Anti-inflammatory Drug [EPC]"
    ],
    "pharm_class_moa": [
      "Cyclooxygenase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Preferred Pharmaceuticals Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68788-4166_65b892f2-8385-4bb0-8121-a58b01e8d13d"